Back
  1. Home
  2. Profile
Profil

Helvenstein Maxime


Main Referenced Co-authors
BLANKERT, Bertrand  (20)
Hambye, Stéphanie  (10)
COLET, Jean-Marie  (5)
Conotte, Raphael  (5)
Vanden Eynde, Jean-Jacques (3)
Main Referenced Keywords
Analytical bioreactor, HepaRG cells, magnetically labeled cells, metabolization test, hepatocytes (1); Bufo Marinus (1); Extraction (1); High Energy Physics - Experiment (1); Marinobufagenin (1);
Main Referenced Unit & Research Centers
UMHAP - Centre de Recherche UMONS-Ambroise Paré (7)
CISMA - Centre Interdisciplinaire de Spectrométrie de Masse (1)
Main Referenced Disciplines
Chemistry (19)
Pharmacy, pharmacology & toxicology (15)
Endocrinology, metabolism & nutrition (10)
Chemical engineering (1)
General & internal medicine (1)

Publications (total 21)

The most downloaded
6 downloads
Lenaerts, C., Helvenstein, M., & Blankert, B. (29 January 2013). Marinobufagenin and its applications in the diagnosis of preeclampsia. Poster session presented at Journée scientifique des doctorants en Sciences Biomédicales et Pharmaceutiques: 'New tools and strategies in identification of pathology-related biomarkers', UMONS, Belgium. https://hdl.handle.net/20.500.12907/19564
The most cited
24 citations (Scopus®)
Fouad, M., Helvenstein, M., & Blankert, B. (2015). Ultra High Performance Liquid Chromatography Method for the Determination of Two Recently FDA Approved TKIs in Human Plasma Using Diode Array Detection. Journal of Analytical Methods in Chemistry. doi:10.1155/2015/215128 https://hdl.handle.net/20.500.12907/1147

Helvenstein, M., Hambye, S., & Blankert, B. (04 April 2017). Hepatocyte-based flow analytical bioreactor for online xenobiotics metabolism bioprediction. Nanobiomedicine, 4, 1-11.
Peer Reviewed verified by ORBi

Helvenstein, M., Stanicki, D., Laurent, S., & Blankert, B. (2015). Interaction between iron oxide nanoparticles and HepaRG cells: a preliminary In vitro evaluation. Journal of Nanomaterials. doi:10.1155/2015/463841
Peer Reviewed verified by ORBi

Helvenstein, M. (2015). 'Bioréacteur à base de cellules magnétiquement marquées pour l'étude de la biotransformation de substances d'intérêt pharmaceutique : développement et évaluation.'. Unpublished doctoral thesis, Université de Mons.
Jury: Blankert, B. (Promotor), Duez, P., Colet, J.-M., Kauffmann, J.-M., Gossuin, Y., & Daali, Y.

Fouad, M., Helvenstein, M., & Blankert, B. (2015). Ultra High Performance Liquid Chromatography Method for the Determination of Two Recently FDA Approved TKIs in Human Plasma Using Diode Array Detection. Journal of Analytical Methods in Chemistry. doi:10.1155/2015/215128
Peer Reviewed verified by ORBi

Helvenstein, M., Hambye, S., & Blankert, B. (15 March 2015). Determination of three tyrosine kinase inhibitors and one active metabolite by a validated UPLC-DAD method in human plasma. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Hambye, S., Helvenstein, M., Vanden Eynde, J. J., & Blankert, B. (15 March 2015). First UPLC-Fluo/PDA quantification method of pentamidine and a new promising analogue in biological fluids. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Helvenstein, M., Fouad, M., & Blankert, B. (15 March 2015). Development and validation of UPLC-DAD method for the determination of two recently FDA approved TKIs in human plasma for therapeutic drug monitoring. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Romoaldo, G., Helvenstein, M., Hambye, S., & Blankert, B. (15 March 2015). Identification et quantification de biomarqueurs d'états émotionnels. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Helvenstein, M., Hambye, S., & Blankert, B. (07 July 2014). Determination of three tyrosine kinase inhibitors and one active metabolite by an identical and validated ultra-performance liquid chromatography-DAD method in human plasma. Current Pharmaceutical Analysis, 10, 161-168.
Peer Reviewed verified by ORBi

Hambye, S., Helvenstein, M., Vanden Eynde, J.-J., & Blankert, B. (23 June 2014). First UPLC-Fluo/PDA quantification method of Pentamidine and a new promising analogue in biological fluids. Poster session presented at Drug Analysis, Liège, Belgium.

Helvenstein, M., Stanicki, D., & Blankert, B. (22 June 2014). In vitro evaluation of the interaction of iron oxide nanoparticles with the HepaRG cells. Poster session presented at Drug Analysis, Liège, Belgium.

Nachtergael, A., Coulembier, O., Dubois, P., Helvenstein, M., Duez, P., Blankert, B., & Mespouille, L. (22 June 2014). Organocatalysis paradigm revised: are metal-free catalysts really harmless? Poster session presented at Drug Analysis, Liège, Belgium.

Helvenstein, M., Hambye, S., & Blankert, B. (22 June 2014). Determination of three tyrosine kinase inhibitors and one active metabolite by a validated UPLC-DAD method in human plasma. Poster session presented at Drug Analysis, Liège, Belgium.

Helvenstein, M., Hambye, S., & Blankert, B. (13 February 2014). UPLC-DAD method validation by accuracy profiles approach of tyrosine kinase inhibitors in human plasma. Poster session presented at 6ème Journée Scientifique du Pôle hainuyer, Mons, Belgium.

Hambye, S., Helvenstein, M., Verdy, L., Kahvecioglu, Z. C., Conotte, R., Vanden Eynde, J.-J., Colet, J.-M., & Blankert, B. (10 February 2014). Ultra High Performance Liquid Chromatography method for the determination of Pentamidine and analog in rat biological fluids. Journal of Pharmaceutical and Biomedical Analysis, 95, 54-60.
Peer Reviewed verified by ORBi

Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (29 October 2013). A similar UPLC-UV method for three tyrosine kinase inhibitors determination in human plasma. Paper presented at 17th Forum of Pharmaceutical Sciences, Spa, Belgium.

Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (30 June 2013). Ultra-performance liquid chromatography method for the determination of tyrosine kinase inhibitors in human plasma. Poster session presented at 24th International Symposium on Pharmaceutical and Biomedical Analysis, Bologne, Italy.

Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (24 May 2013). Tyrosine kinase inhibitors quantification by UPLC-UV in human plasma. Poster session presented at Health Institute Day, Mons, Umons, Belgium.

Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (12 March 2013). Tyrosine kinase inhibitors quantification in human plasma. Poster session presented at 7ième Matinée des Chercheurs, Mons, Belgium.

Hambye, S., Ansseau, E., Helvenstein, M., Carminati, A., Vanden Eynde, J.-J., Belayew, A., & Blankert, B. (12 March 2013). Analytical developments and biological evaluation (in Steinert desease) of Pentamidine and new analogs. Poster session presented at 7ième Matinée des Chercheurs, Mons, Belgium.

Lenaerts, C., Helvenstein, M., & Blankert, B. (29 January 2013). Marinobufagenin and its applications in the diagnosis of preeclampsia. Poster session presented at Journée scientifique des doctorants en Sciences Biomédicales et Pharmaceutiques: 'New tools and strategies in identification of pathology-related biomarkers', UMONS, Belgium.

Contact ORBi